Trauma Care Readiness and Coordination Cooperative Agreement
- Response deadline
- Sep 18, 2026 Closed
- Date posted
- Aug 19, 2026
- Source
- Open notice
Description
A trauma system is, “…an organized, inclusive approach to facilitating and coordinating a multidisciplinary system response to severely injured patients.”[14] Coordination across prehospital entities (e.g., EMS) and hospitals signal an effective trauma system, where patients can get the right level of care they need. Access to trauma care in the United States is inconsistent. For example, 1 in 3 Americans live in a region with incomplete trauma care,[15] and 30 million Americans live over 60 minutes from a trauma care center.[16] The Trauma Care Readiness and Coordination Program supports ASPR’s goal of strengthening state and local preparedness by funding and supporting efforts to improve coordination across EMS, pre-hospital providers, and hospitals.[17] Through this program, ASPR will help recipients test scalable models that improve trauma system readiness and patient access to the right level of care, ultimately improving health outcomes and saving lives.
Classifications
- NAICS93.817
Documents (1)
- ep-u3r-26-002.pdfapplication/pdf371 KBNot yet available
Contacts
- jennifer.hannah@hhs.gov770-488-2756
Similar contracts
- Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)Due Mar 5, 2029
- NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed)Due May 26, 2027
- Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)Due Jan 10, 2028
- Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)Due Feb 8, 2028
- NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food SpecimensDue Apr 1, 2027
- Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional)Due Jul 14, 2026